Intracoronary Stenting and Antithrombotic Regimen Rapid Early Action for Coronary Treatment - ISAR REACT

Description:

The goal of the ISAR REACT study was to evaluate whether treatment with the glycoprotein (GP) IIb/IIIa inhibitor abciximab reduces postprocedure ischemic complications in low-risk patients pretreated with clopidogrel who undergo coronary stenting.